COVID-19 in Rheumatic Disease Patients
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), which was initially identified in...
Read More
BreakingMed. EditorsPick
In a No Holds Barred Statement, the American Academy of Neurology Offers Advice for Members on Prescribing Aducanumab
AAN statement leaves little to the imagination In response to the controversy concerning...
Read More
Covid-19: ACAAI Updates Guidance on Risk of Allergic Reactions with mRNA Vaccines
Key: review patient’s vaccine history The American College of Allergy, Asthma, and Immunology...
Read More
RA Biologic Tocilizumab Shows Promise in Covid-19-related Pneumonia
Previous clinical trials showed little benefit for the drug Among patients hospitalized with...
Read More